Joan Harvey, SVP, Consumer Health Engagement & Behavioral Health at Cigna and Rich Berner, CEO of MDLIVE, share insights on using AI and new technology to meet consumers where they are and provide better health care.
Mike Mussallem, Chairman & CEO of Edwards Lifesciences shares insights on harnessing technology to advance consumer-focused care and using data to make evidence-based breakthroughs that drive transformational change in care delivery.
Udvarhelyi discusses how Blue Cross Blue Shield is enabling patient-driven care by looking at three key questions.
Humana Segment President, Beth Bierbower and Geisinger EVP & Chief Innovation Officer, Karen Murphy, on the stigma of addiction and mental health disorders and how to address the public health crisis we are struggling with today.
Blue Cross and Blue Shield of Minnesota President & CEO on the need to switch to value-based care and the lessons we can learn from other consumer-focused industries.
Marc Boom discusses what Houston Methodist is doing to increase efficiency and lower costs while keeping the patient at the heart of its work.
GE Ventures Former CEO Sue Siegel and Section 32 Managing Partner Michael Pellini discuss the four aspects of health care coming together to advance diagnostics in ways never before possible. This is especially important given that diagnostics have historically fallen short compared to other sectors in terms of both spending and research.
Advantia Health Founder & CEO Sean Glass shares insights about what Advantia is doing to address gaps in perinatal, pregnancy and postpartum care and move the needle for all.
Dean discusses the importance of shared values and common goals in the recent CHI/Dignity Health merger and his work in addressing drivers of health and health inequities.
Feinberg said the transformation will require a new business model that does not involve ads or targeting individuals for health care services the way Google’s other businesses do today.
How CEOs are making their business models work to embrace the state’s forward-looking agenda to invest $650 million in social determinants and other new ways of driving down costs.